Clorox (CLX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Clorox

    NYSE: CLX · Real-Time Price · USD
    123.18
    0.93 (0.76%)
    At close: Oct 03, 2025, 3:59 PM
    123.40
    0.18%
    After-hours: Oct 03, 2025, 07:44 PM EDT

    Clorox Cash Flow Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Net Income
    		 824M 292M 161M 471M 719M
    Depreciation & Amortization
    		 219M 235M 236M 224M 211M
    Stock-Based Compensation
    		 81M 74M 73M 52M 50M
    Other Working Capital
    		 -5M -122M 152M 50M -122M
    Other Non-Cash Items
    		 86M 435M 483M 133M 339M
    Deferred Income Tax
    		 -18M -100M -149M 5M -32M
    Change in Working Capital
    		 -211M -241M 354M -99M -11M
    Operating Cash Flow
    		 981M 695M 1.16B 786M 1.28B
    Capital Expenditures
    		 -220M -212M -228M -251M -331M
    Cash Acquisitions
    		 128M 17M n/a n/a -85M
    Purchase of Investments
    		 n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 -2M 20M 5M 22M -36M
    Investing Cash Flow
    		 -94M -175M -223M -229M -452M
    Debt Repayment
    		 n/a -45M -188M -83M n/a
    Common Stock Repurchased
    		 -332M n/a n/a -25M -905M
    Dividend Paid
    		 -602M -595M -583M -571M -558M
    Other Financial Acitivies
    		 10M -16M -15M -15M -31M
    Financial Cash Flow
    		 -924M -655M -753M -689M -1.39B
    Net Cash Flow
    		 -37M -161M 182M -138M -555M
    Free Cash Flow
    		 761M 483M 930M 535M 945M

    Add to Watchlist